Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra
The FDA has approved Merck's cholesterol-lowering daily pill Lipfendra. The PCSK9 inhibitor has been cleared for adults with hypercholesterolemia.
Kevin Dunleavy
Jul 16, 2026 9:30am
Merck touts Keytruda front-line win in endometrial cancer subtype
Jul 15, 2026 3:33pm
Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials
Jun 9, 2026 11:20am
Lilly, Boehringer slash investment plans in Germany
Jun 3, 2026 3:10pm
AZ gains on Merck with 2nd bladder cancer nod for Imfinzi
May 28, 2026 4:39pm
In endometrial cancer, Merck and Kelun score with sac-TMT
May 18, 2026 11:21am
